{"entity":{"id":"jacobio-pharmaceuticals","kind":"company","name":"Jacobio Pharmaceuticals","aka":["Jacobio Pharmaceuticals Co., Ltd."],"tldr":"Jacobio Pharmaceuticals is a Chinese developer in Beijing that sponsors 6 registered cancer trials of JAB-30355 and JAB-2485.","summary":"Jacobio Pharmaceuticals appears on ClinicalTrials.gov as the industry sponsor of 6 interventional cancer trials (phase 1/2), testing JAB-30355, JAB-2485, JAB-23E73, JAB-8263 in solid tumors, er+ breast cancer, triple negative breast cancer, tnbc, arid1a gene mutation. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.","asOf":"2026-09-11","links":[{"label":"ClinicalTrials.gov: trials sponsored by Jacobio Pharmaceuticals","url":"https://clinicaltrials.gov/search?spons=Jacobio%20Pharmaceuticals"}],"tags":["ctgov-sponsor","china","registry-only"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct06386146","nct05490472","nct06973564","nct04686682","nct06959615","nct07640295"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"Beijing, China","country":"CN","companyType":"biotech","investors":[],"funding":[]},"route":"/companies/jacobio-pharmaceuticals/","neighbours":{"trial":[{"id":"nct04686682","kind":"trial","name":"A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors","route":"/trials/nct04686682/"},{"id":"nct06959615","kind":"trial","name":"A Phase I/IIa Study of JAB-23E73 in Patients With Advanced Solid Tumors Harboring KRAS Gene Alteration","route":"/trials/nct06959615/"},{"id":"nct06973564","kind":"trial","name":"JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration","route":"/trials/nct06973564/"},{"id":"nct05490472","kind":"trial","name":"JAB-2485 Activity in Adult Patients With Advanced Solid Tumors","route":"/trials/nct05490472/"},{"id":"nct06386146","kind":"trial","name":"JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation","route":"/trials/nct06386146/"},{"id":"nct07640295","kind":"trial","name":"Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations","route":"/trials/nct07640295/"}]}}